Skip to main content
. Author manuscript; available in PMC: 2012 Jul 25.
Published in final edited form as: J Thromb Haemost. 2010 May 4;8(7):1614–1623. doi: 10.1111/j.1538-7836.2010.03900.x

Fig. 2.

Fig. 2

Influence of administration of granulocyte colony-stimulating factor (G-CSF) on hematopoietic progenitor cell (HPC) mobilization on CD34+ cells and CD34+ subpopulations in peripheral blood (PB) leukocytes. (A) CD34+ cells as a proportion of total leukocytes in normal PB and in G-CSF-mobilized PB from healthy donors and from hematologic malignancy patients in remission (mPB). (B) The proportion of CD34+ cells coexpressing CD133 in normal PB and in G-CSF-mobilized PB from healthy donors and from hematologic malignancy patients in remission. (C) The proportion of CD34+ cells with low to negligible CD45 expression in normal PB and in G-CSF-mobilized PB from healthy donors and from hematologic malignancy patients in remission. (D) Absolute numbers of circulating HPC subpopulations per liter of PB: all CD34+ cells; CD34+ cells coexpressing CD133; and CD34+ cells low in CD45 expression. The results are calculated from research laboratory determination of total leukocyte counts and proportional subpopulations, expressed as mean ± standard deviation (SD). A P-value of < 0.05 was considered to indicate statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001). Mob, mobilized; WBC, white blood cell.